Related Experiment Video
Updated: Nov 17, 2025

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
Published on: April 28, 2020
Comparing CLIF-C ACLF, CLIF-C ACLFlactate, and CLIF-C ACLF-D Prognostic Scores in Acute-on-Chronic Liver Failure
Chao-Cheng Kuo1, Chien-Hao Huang1,2, Ching Chang1
1Division of Hepatology, Department of Gastroenterology and Hepatology, Chang-Gung Memorial Hospital, Linkou Medical Center, Taoyuan 333423, Taiwan.
Insights
The CLIF-C ACLF-D score is a superior predictor of mortality in patients with acute-on-chronic liver failure (ACLF). This prognostic tool aids in evaluating outcomes for liver cirrhosis patients awaiting transplantation.
Area of Science:
- Hepatology
- Critical Care Medicine
- Prognostic Biomarkers
Background:
- Patients with liver cirrhosis face a heightened risk of developing acute-on-chronic liver failure (ACLF).
- ACLF presents a poor prognosis with high short-term mortality, limiting liver transplant opportunities.
- Accurate prognostic evaluation is crucial for ACLF patients before transplant consideration.
Purpose of the Study:
- To compare the predictive performance of three prognostic scores for ACLF patients.
- To evaluate the CLIF-C ACLF, CLIF-C ACLF-D, and CLIF-C ACLFlactate scores in predicting mortality.
- To identify the most effective score for assessing outcomes in critical ACLF.
Main Methods:
- A cohort of 135 ACLF patients admitted to CGMH (Taiwan) from Nov 2012 to Apr 2015 were tracked until Apr 2017.
- Three prognostic scores (CLIF-C ACLF, CLIF-C ACLF-D, CLIF-C ACLFlactate) were assessed.
- Area Under the Receiver Operating Characteristic Curve (AUROC) analysis was used to compare mortality predictions at various time points (28 days to 365 days).
Main Results:
- CLIF-C ACLF and CLIF-C ACLF-D scores outperformed CLIF-C ACLFlactate in predicting 28-day mortality.
- The CLIF-C ACLF-D score demonstrated the highest AUROC for overall mortality prediction.
- CLIF-C ACLF-D also showed superior predictive power for 90, 180, and 365-day mortality.
Conclusions:
- CLIF-C ACLF and CLIF-C ACLF-D scores are significant predictors of outcomes in critically ill liver cirrhosis patients with ACLF.
- The CLIF-C ACLF-D score exhibits superior predictive capability for short-term and long-term mortality (3 months to 1 year).
- This study highlights the utility of CLIF-C ACLF-D for prognostic assessment in ACLF management.
Abstract:
Patients with liver cirrhosis have a higher risk of developing acute-on-chronic liver failure (ACLF). Poor prognosis with a high rate of short-term mortality leads to limited opportunities for further liver transplantation. Thus, precise prognostic evaluation of patients with ACLF is necessary before transplant surgery. In this study, a total of one hundred and thirty-five patients with ACLF admitted to the hepato-gastroenterologic intensive care unit (ICU) for intensive monitoring and treatment at Chang-Gung Memorial Hospital (CGMH, Linkou, Taiwan) were screened from November 2012 to April 2015 and tracked until April 2017. Three new prognostic scores of ACLF, including CLIF-C ACLF (Chronic Liver Failure Consortium Acute-on-chronic Liver Failure score), CLIF-C ACLF-D (CLIF-C ACLF Development score), and CLLF-C ACLFlactate (lactate-adjusted CLIF-C ACLF score) were compared. The primary outcome considered was overall mortality. Mortality predictions at 28, 90, 180, and 365 days were also calculated. By area under the receiver operating characteristic curve (AUROC) analysis, the CLIF-C ACLF and CLIF-C ACLF-D scores were superior to CLIF-C ACLFlactate scores in predicting 28-day mortality. The CLIF-C ACLF-D score had the highest AUROC in predicting overall mortality as well as at 90, 180, and 365 days. In conclusion, our study demonstrates that CLIF-C ACLF and CLIF-C ACLF-D scores are significant predictors of outcome in critical patients with liver cirrhosis and ACLF. The CLIF-C ACLF-D score may have a superior predictive power for the prediction of 3-month, 6-month, and one-year mortality.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Acute Coronary Syndrome III: Diagnostic Studies

